Tag: Prescription Drugs
Nivolumab Plus Ipilimumab Tops Sunitinib for Advanced Renal CA
Overall survival, objective response higher than sunitinib for untreated clear-cell advanced RCC
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis
Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis
Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD
Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor
Unique Risks Associated With Texting Medical Orders
Institute of Safe Medication Practices indicates risks such as abbreviations, autocorrection
Adjuvant Long-Acting Muscarinic Antagonist Improves Asthma
Versus adjuvant placebo, LAMA or LABA plus inhaled corticosteroids lowers risk of asthma exacerbations
ACC: Low-Dose Triple Combo Pill Effective for Rapid BP Control
Greater chance of achieving blood pressure target level with combo pill strategy versus usual care
Drug Copayments Often Exceed Prescription Drug Costs
Overpayments affect 23 percent of all prescriptions; more common with generic drugs
PTs Support Interprofessional Model of Care With Pharmacists
Most survey respondents reported a positive perception of interactions with pharmacists
ACC: Febuxostat Noninferior to Allopurinol for Gout, CVD
Noninferior for rates of adverse cardiovascular events; tied to higher all-cause, cardiovascular mortality
NCCN Recommends New Drugs Beyond FDA-Approved Indications
NCCN recommended 47 FDA-approved drugs for 113 indications; 39 percent were extra recommendations
